We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03.
- Authors
D'Addario, G; Rauch, D; Stupp, R; Pless, M; Stahel, R; Mach, N; Jost, L; Widmer, L; Tapia, C; Bihl, M; Mayer, M; Ribi, K; Lerch, S; Bubendorf, L; Betticher, D C
- Abstract
Gefitinib is active in patients with pretreated non-small-cell lung cancer (NSCLC). We evaluated the activity and toxicity of gefitinib first-line treatment in advanced NSCLC followed by chemotherapy at disease progression.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Vol 19, Issue 4, p739
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdm564